BR112014008815A2 - derivados de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina, composição farmacêutica, método para fabricar uma composição farmacêutica e método para fabricar um derivado de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina - Google Patents
derivados de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina, composição farmacêutica, método para fabricar uma composição farmacêutica e método para fabricar um derivado de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidinaInfo
- Publication number
- BR112014008815A2 BR112014008815A2 BR112014008815A BR112014008815A BR112014008815A2 BR 112014008815 A2 BR112014008815 A2 BR 112014008815A2 BR 112014008815 A BR112014008815 A BR 112014008815A BR 112014008815 A BR112014008815 A BR 112014008815A BR 112014008815 A2 BR112014008815 A2 BR 112014008815A2
- Authority
- BR
- Brazil
- Prior art keywords
- phenylamino
- amino
- making
- pharmaceutical composition
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
resumo derivados de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina, composição farmacêutica, método para fabricar uma composição farmacêutica e método para fabricar um derivado de 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina a presente invenção refere-se a derivados de 5-amino-3-fenilamino-5-fenilpirazolo[3,4-d]pirimidina da fórmula geral i: (i) ou sais farmaceuticamente aceitáveis ou profármacos dos mesmos, onde pelo menos um átomo de hidrogênio em pelo menos um dos grupos fenila a e b é substituído com um substituinte rh, que tem uma constante hammett ?p maior que 0,23. a presente invenção também se refere ao método de fabricação. para compostos correspondentes, foi surpreendentemente determinada uma alta atividade específica contra vírus, particularmente rinovírus e picornavírus. além disso, os compostos são muito bem tolerados. por essas razões, os compostos são adequados para o tratamento de infecções virais e como fármacos. 1/1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201110116373 DE102011116373A1 (de) | 2011-10-14 | 2011-10-14 | Methode zur Herstellung von 4-Amino-3-arylamino-6-arylpyrazolo[3, 4-d]pyrimidinen |
| DE102011116373.9 | 2011-10-14 | ||
| DE102011116384.4 | 2011-10-20 | ||
| DE102011116384 | 2011-10-20 | ||
| PCT/EP2012/070403 WO2013053942A1 (de) | 2011-10-14 | 2012-10-15 | 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-derivate, deren herstellung und deren verwendung als antivirale wirkstoffe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014008815A2 true BR112014008815A2 (pt) | 2017-04-25 |
| BR112014008815B1 BR112014008815B1 (pt) | 2021-01-12 |
Family
ID=47071252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014008815-2A BR112014008815B1 (pt) | 2011-10-14 | 2012-10-15 | 4-amino-3-fenilamino-6-fenilpirazolo[3,4-d]pirimidina, composição farmacêutica método para preparar uma composição farmacêutica e método para fabricar um 4-amino-3-fenilamino-6- fenilpirazolo[3,4-d]pirimidina |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9790225B2 (pt) |
| EP (1) | EP2766367B1 (pt) |
| JP (1) | JP6071012B2 (pt) |
| KR (1) | KR20140095467A (pt) |
| CN (1) | CN103946224A (pt) |
| AU (1) | AU2012322750B2 (pt) |
| BR (1) | BR112014008815B1 (pt) |
| CA (1) | CA2850439C (pt) |
| DK (1) | DK2766367T3 (pt) |
| ES (1) | ES2924828T3 (pt) |
| HR (1) | HRP20220928T1 (pt) |
| HU (1) | HUE059217T2 (pt) |
| IL (1) | IL231934A (pt) |
| LT (1) | LT2766367T (pt) |
| MX (1) | MX2014003987A (pt) |
| PL (1) | PL2766367T3 (pt) |
| PT (1) | PT2766367T (pt) |
| RU (1) | RU2014118953A (pt) |
| SG (2) | SG10201602846TA (pt) |
| SI (1) | SI2766367T1 (pt) |
| WO (1) | WO2013053942A1 (pt) |
| ZA (1) | ZA201402226B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2662822T3 (es) | 2015-03-04 | 2018-04-09 | Scandion Oncology A/S | Derivados de 4-amino-3-fenilamino-6-fenilpirazol[3,4-d]pirimidina para uso como inhibidores de la BCRP en tratamientos terapéuticos |
| KR102205570B1 (ko) | 2018-09-12 | 2021-01-20 | 김홍기 | 뿌리식물 수경재배용 시트 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2965643A (en) | 1960-12-20 | Derivatives of pyrazolo | ||
| US3551428A (en) | 1956-02-10 | 1970-12-29 | Ciba Geigy Corp | New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines |
| DE3712735A1 (de) | 1987-04-15 | 1988-11-10 | Boehringer Mannheim Gmbh | Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel |
| CA2100863A1 (en) | 1991-01-23 | 1992-07-24 | David A. Bullough | Adenosine kinase inhibitors |
| TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
| US5646152A (en) | 1994-06-15 | 1997-07-08 | Pfizer Inc. | Methods of administering CRF antagonists |
| CZ27399A3 (cs) | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
| DE102006029074A1 (de) * | 2006-06-22 | 2007-12-27 | Friedrich-Schiller-Universität Jena | 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe |
-
2012
- 2012-10-15 HU HUE12775659A patent/HUE059217T2/hu unknown
- 2012-10-15 RU RU2014118953/04A patent/RU2014118953A/ru not_active Application Discontinuation
- 2012-10-15 PT PT127756591T patent/PT2766367T/pt unknown
- 2012-10-15 SG SG10201602846TA patent/SG10201602846TA/en unknown
- 2012-10-15 AU AU2012322750A patent/AU2012322750B2/en active Active
- 2012-10-15 SG SG11201401351PA patent/SG11201401351PA/en unknown
- 2012-10-15 WO PCT/EP2012/070403 patent/WO2013053942A1/de active Application Filing
- 2012-10-15 MX MX2014003987A patent/MX2014003987A/es unknown
- 2012-10-15 ES ES12775659T patent/ES2924828T3/es active Active
- 2012-10-15 DK DK12775659.1T patent/DK2766367T3/da active
- 2012-10-15 HR HRP20220928TT patent/HRP20220928T1/hr unknown
- 2012-10-15 SI SI201232005T patent/SI2766367T1/sl unknown
- 2012-10-15 PL PL12775659.1T patent/PL2766367T3/pl unknown
- 2012-10-15 JP JP2014535117A patent/JP6071012B2/ja active Active
- 2012-10-15 KR KR1020147009385A patent/KR20140095467A/ko not_active Application Discontinuation
- 2012-10-15 LT LTEPPCT/EP2012/070403T patent/LT2766367T/lt unknown
- 2012-10-15 CN CN201280050298.6A patent/CN103946224A/zh active Pending
- 2012-10-15 EP EP12775659.1A patent/EP2766367B1/de active Active
- 2012-10-15 CA CA2850439A patent/CA2850439C/en active Active
- 2012-10-15 US US14/350,885 patent/US9790225B2/en active Active
- 2012-10-15 BR BR112014008815-2A patent/BR112014008815B1/pt active IP Right Grant
-
2014
- 2014-03-26 ZA ZA2014/02226A patent/ZA201402226B/en unknown
- 2014-04-03 IL IL231934A patent/IL231934A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK2766367T3 (da) | 2022-08-01 |
| EP2766367A1 (de) | 2014-08-20 |
| MX2014003987A (es) | 2014-09-22 |
| IL231934A0 (en) | 2014-05-28 |
| HUE059217T2 (hu) | 2022-10-28 |
| IL231934A (en) | 2017-03-30 |
| PL2766367T3 (pl) | 2022-08-22 |
| PT2766367T (pt) | 2022-08-12 |
| CA2850439C (en) | 2020-04-07 |
| US9790225B2 (en) | 2017-10-17 |
| WO2013053942A1 (de) | 2013-04-18 |
| ES2924828T3 (es) | 2022-10-11 |
| AU2012322750B2 (en) | 2016-11-10 |
| NZ623573A (en) | 2016-08-26 |
| US20140296259A1 (en) | 2014-10-02 |
| JP6071012B2 (ja) | 2017-02-01 |
| EP2766367B1 (de) | 2022-05-18 |
| ZA201402226B (en) | 2015-05-27 |
| LT2766367T (lt) | 2022-08-25 |
| AU2012322750A1 (en) | 2014-04-24 |
| CA2850439A1 (en) | 2013-04-18 |
| SG10201602846TA (en) | 2016-05-30 |
| CN103946224A (zh) | 2014-07-23 |
| SG11201401351PA (en) | 2014-08-28 |
| HRP20220928T1 (hr) | 2022-10-28 |
| RU2014118953A (ru) | 2015-11-20 |
| SI2766367T1 (sl) | 2022-10-28 |
| JP2014528468A (ja) | 2014-10-27 |
| BR112014008815B1 (pt) | 2021-01-12 |
| KR20140095467A (ko) | 2014-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012018529A2 (pt) | inibidores do vírus de hepatite c, sua composição farmacêutica e seu uso, e método para inibição da replicação de um vírus contendo rna | |
| BR112013026345A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv | |
| BR112014013661A2 (pt) | Derivados de nucleosídeos 2,4-difluoro-2-metil substituídos como inibidores de replicação de hcv-rna | |
| BR112013021537A2 (pt) | derivados de tiazolilpenil-benzenosulfonamido como inibidores da quinase | |
| BR112017026159A2 (pt) | inibidores heterocíclicos de erk1 e erk2 e seu uso no tratamento de câncer | |
| BR112016006651B8 (pt) | compostos derivados de quinolizina substituídos, composição farmacêutica que os compreende e uso dos referidos compostos | |
| BR112015028501B8 (pt) | Compostos derivados de bipirazol, seus sais, composição compreendendo o composto ou o sal, método de inibição in vitro de uma atividade de jak1, e processo de preparação de sal de ácido fosfórico | |
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| BR112014000713A2 (pt) | derivados de indol substituído como moduladores de gama secretase | |
| BR112015003188A2 (pt) | Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
| BR112014031068A2 (pt) | derivados piridinona e piridazinona | |
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| BR112014015066A2 (pt) | derivados de nucleosídeos 4'azido-3'-flúor substituídos como inibidores de replicação do rna de hcv | |
| EA201391098A1 (ru) | C-28-амины c-3-модифицированных производных бетулиновой кислоты в качестве ингибиторов созревания вич | |
| BR112014026383A2 (pt) | derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl1 | |
| BR112013018601A2 (pt) | composto, uso de composto, composição farmacêutica, e, produto farmacêutico | |
| BR112012027062B8 (pt) | composto, processo para a preparação de um composto e usos do mesmo | |
| CY1120515T1 (el) | Παραγωγο κυκλοαλκυλικο οξεος, μεθοδος παρασκευης και φαρμακευτικη εφαρμογη αυτου | |
| BR112012017402A2 (pt) | inibidores de vírus de flaviviridae | |
| UY32174A (es) | Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones | |
| BR112014018959A8 (pt) | Compostos, composições farmacêuticas, utilizações de um composto e métodos para o tratamento do câncer | |
| BR112014008495B8 (pt) | Composto inibidor da proteína quinase, composição farmacêutica compreendendo-o e uso do mesmo para a fabricação de um medicamento para o tratamento de câncer | |
| BR112015021856A2 (pt) | processos e intermediários para a preparação de um medicamento | |
| UA115868C2 (uk) | Гетероциклічні сполуки, лікарські засоби, які містять зазначені сполуки, їх застосування і способи їх одержання |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |